Annual FCF
N/A
December 31, 2024
Summary
- IRMD annual free cash flow is not available.
Performance
IRMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
N/A
December 31, 2024
Summary
- IRMD quarterly free cash flow is not available.
Performance
IRMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
December 31, 2024
Summary
- IRMD TTM free cash flow is not available.
Performance
IRMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IRMD Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IRMD Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
IRadimed Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.10 M(-4.9%) | $17.16 M(+31.9%) |
| Jun 2024 | - | $5.37 M(+57.7%) | $13.01 M(+20.7%) |
| Mar 2024 | - | $3.40 M(+3.8%) | $10.77 M(+97.4%) |
| Dec 2023 | $5.46 M(-33.2%) | $3.28 M(+243.9%) | $5.46 M(+15.0%) |
| Sep 2023 | - | $953.70 K(-69.6%) | $4.75 M(-33.9%) |
| Jun 2023 | - | $3.14 M(-264.1%) | $7.17 M(+36.5%) |
| Mar 2023 | - | -$1.91 M(-174.4%) | $5.26 M(-35.7%) |
| Dec 2022 | $8.17 M(-22.3%) | $2.57 M(-24.1%) | $8.17 M(-7.0%) |
| Sep 2022 | - | $3.38 M(+178.0%) | $8.79 M(+2.6%) |
| Jun 2022 | - | $1.22 M(+21.5%) | $8.56 M(-20.3%) |
| Mar 2022 | - | $1.00 M(-68.6%) | $10.75 M(+2.2%) |
| Dec 2021 | $10.52 M(+103.0%) | $3.19 M(+0.9%) | $10.52 M(+8.2%) |
| Sep 2021 | - | $3.16 M(-7.2%) | $9.72 M(+24.8%) |
| Jun 2021 | - | $3.40 M(+342.6%) | $7.79 M(+56.3%) |
| Mar 2021 | - | $769.10 K(-67.9%) | $4.98 M(-3.8%) |
| Dec 2020 | $5.18 M(-46.8%) | $2.39 M(+95.5%) | $5.18 M(-20.4%) |
| Sep 2020 | - | $1.22 M(+104.7%) | $6.51 M(-21.8%) |
| Jun 2020 | - | $597.90 K(-38.1%) | $8.32 M(-18.0%) |
| Mar 2020 | - | $966.30 K(-74.0%) | $10.14 M(+4.0%) |
| Dec 2019 | $9.75 M(+37.1%) | $3.72 M(+22.5%) | $9.75 M(+2.9%) |
| Sep 2019 | - | $3.04 M(+25.4%) | $9.47 M(+33.2%) |
| Jun 2019 | - | $2.42 M(+322.7%) | $7.11 M(+15.8%) |
| Mar 2019 | - | $572.50 K(-83.4%) | $6.14 M(-13.7%) |
| Dec 2018 | $7.11 M | $3.44 M(+409.4%) | $7.11 M(+44.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $675.70 K(-53.3%) | $4.93 M(-16.5%) |
| Jun 2018 | - | $1.45 M(-6.3%) | $5.90 M(+29.3%) |
| Mar 2018 | - | $1.55 M(+22.8%) | $4.56 M(+76.1%) |
| Dec 2017 | $2.59 M(-67.1%) | $1.26 M(-23.6%) | $2.59 M(-18.2%) |
| Sep 2017 | - | $1.65 M(+1375.3%) | $3.17 M(-34.0%) |
| Jun 2017 | - | $111.60 K(-126.2%) | $4.80 M(-13.0%) |
| Mar 2017 | - | -$425.20 K(-123.2%) | $5.51 M(-30.0%) |
| Dec 2016 | $7.88 M(+7.5%) | $1.83 M(-44.0%) | $7.88 M(-7.3%) |
| Sep 2016 | - | $3.28 M(+295.8%) | $8.51 M(+13.5%) |
| Jun 2016 | - | $827.80 K(-57.4%) | $7.49 M(-9.3%) |
| Mar 2016 | - | $1.94 M(-21.0%) | $8.26 M(+12.6%) |
| Dec 2015 | $7.33 M(+270.5%) | $2.46 M(+8.6%) | $7.33 M(+88.3%) |
| Sep 2015 | - | $2.26 M(+41.8%) | $3.89 M(+51.0%) |
| Jun 2015 | - | $1.60 M(+57.3%) | $2.58 M(+1.6%) |
| Mar 2015 | - | $1.02 M(-203.4%) | $2.54 M(+28.3%) |
| Dec 2014 | $1.98 M(+54.3%) | -$981.50 K(-203.4%) | $1.98 M(-46.2%) |
| Sep 2014 | - | $949.40 K(-39.0%) | $3.68 M(+30.3%) |
| Jun 2014 | - | $1.56 M(+242.4%) | $2.82 M(+55.9%) |
| Mar 2014 | - | $454.70 K(-36.8%) | $1.81 M(+41.3%) |
| Dec 2013 | $1.28 M(-4.8%) | $719.70 K(+674.7%) | $1.28 M(+127.8%) |
| Sep 2013 | - | $92.90 K(-82.9%) | $563.00 K(+19.8%) |
| Jun 2013 | - | $544.80 K(-829.3%) | $470.10 K(-729.3%) |
| Mar 2013 | - | -$74.70 K | -$74.70 K |
| Dec 2012 | $1.35 M | - | - |
FAQ
- What is the all time high annual FCF for IRadimed?
- What is the all time high quarterly FCF for IRadimed?
- What is the all time high TTM FCF for IRadimed?
What is the all time high annual FCF for IRadimed?
IRadimed all-time high annual free cash flow is $10.52 M
What is the all time high quarterly FCF for IRadimed?
IRadimed all-time high quarterly free cash flow is $5.37 M
What is the all time high TTM FCF for IRadimed?
IRadimed all-time high TTM free cash flow is $17.16 M